The present invention provides compounds having store overload-induced Ca.sup.2+ release (SOICR) inhibitory activity and methods for producing and using the same. In particular, compounds of the invention is of the formula: R.sup.1X.sup.1-L-X.sup.2R.sup.2, wherein R.sup.1, X.sup.1, L, X.sup.2, and R.sup.2 are those defined herein.

The present invention provides compounds having store overload-induced Ca.sup.2+ release (SOICR) inhibitory activity and methods for producing and using the same. In particular, compounds of the invention is of the formula: R.sup.1X.sup.1-L-X.sup.2R.sup.2, wherein R.sup.1, X.sup.1, L, X.sup.2, and R.sup.2 are those defined herein.

An amine of formula (I) in a curing agent for epoxy resins, a curing agent for epoxy resins containing the amine of formula (I) and resultant epoxy resin compositions which can be used particularly as low-emission room-temperature-curing epoxy resin coatings demonstrating good workability, rapid curing, a high degree of hardness and high surface quality. The amine of formula (I) is low-odour, can be handled well at room temperature even without dilution, and can be produced at high purity in a simple process.

An amine of formula (I) in a curing agent for epoxy resins, a curing agent for epoxy resins containing the amine of formula (I) and resultant epoxy resin compositions which can be used particularly as low-emission room-temperature-curing epoxy resin coatings demonstrating good workability, rapid curing, a high degree of hardness and high surface quality. The amine of formula (I) is low-odour, can be handled well at room temperature even without dilution, and can be produced at high purity in a simple process.

Methods of making cocrystal compositions of metoprolol and dabigatran bases with enantiomers of theanine.

The present invention relates to compounds of formula (I) that are inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF- mediated conditions: Formula (I)

The present invention relates to compounds of formula (I) that are inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF- mediated conditions: Formula (I)

Methods of treating and preventing conditions by employing cocrystal compositions of metoprolol and dabigatran bases with enantiomers of theanine.

Cocrystal compositions of metoprolol and dabigatran bases with enantiomers of theanine.

Methods of making cocrystal compositions of metoprolol and dabigatran bases with enantiomers of theanine.